BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 25764107)

  • 21. Different types of chronic inflammatory demyelinating polyneuropathy have a different clinical course and response to treatment.
    Jann S; Beretta S; Bramerio MA
    Muscle Nerve; 2005 Sep; 32(3):351-6. PubMed ID: 16003765
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A European multicentre reappraisal of distal compound muscle action potential duration in chronic inflammatory demyelinating polyneuropathy.
    Rajabally YA; Lagarde J; Cassereau J; Viala K; Fournier E; Nicolas G
    Eur J Neurol; 2012 Apr; 19(4):638-42. PubMed ID: 22136662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic criteria of chronic inflammatory demyelinating polyneuropathy in diabetes mellitus.
    Lotan I; Hellman MA; Steiner I
    Acta Neurol Scand; 2015 Oct; 132(4):278-83. PubMed ID: 25819084
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparative study of chronic inflammatory demyelinating polyradiculoneuropathy with and without diabetes mellitus.
    Kalita J; Misra UK; Yadav RK
    Eur J Neurol; 2007 Jun; 14(6):638-43. PubMed ID: 17539941
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic usefulness of plexus magnetic resonance imaging in chronic inflammatory demyelinating polyradiculopathy without electrodiagnostic criteria of demyelination.
    Fargeot G; Viala K; Theaudin M; Labeyrie MA; Costa R; Léger JM; Adams D; Vandendries C; Labeyrie C
    Eur J Neurol; 2019 Apr; 26(4):631-638. PubMed ID: 30431216
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined central and peripheral demyelination: Clinical features, diagnostic findings, and treatment.
    Cortese A; Franciotta D; Alfonsi E; Visigalli N; Zardini E; Diamanti L; Prunetti P; Osera C; Gastaldi M; Berzero G; Pichiecchio A; Piccolo G; Lozza A; Piscosquito G; Salsano E; Ceroni M; Moglia A; Bono G; Pareyson D; Marchioni E
    J Neurol Sci; 2016 Apr; 363():182-7. PubMed ID: 27000248
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relapsing demyelinating disease affecting both the central and peripheral nervous systems.
    Zéphir H; Stojkovic T; Latour P; Lacour A; de Seze J; Outteryck O; Maurage CA; Monpeurt C; Chatelet P; Ovelacq E; Vermersch P
    J Neurol Neurosurg Psychiatry; 2008 Sep; 79(9):1032-9. PubMed ID: 18208860
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Importance of the nerve biopsy for the diagnosis of atypical forms of chronic inflammatory demyelinating polyradiculoneuritis: 8 cases].
    Vallat JM; Tabaraud F; Magy L; Couratier P
    Bull Acad Natl Med; 2003; 187(2):387-99; discussion 399-403. PubMed ID: 14556448
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of sensitivity and specificity among 15 criteria for chronic inflammatory demyelinating polyneuropathy.
    Breiner A; Brannagan TH
    Muscle Nerve; 2014 Jul; 50(1):40-6. PubMed ID: 24338746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cutting edge of diagnosis and treatment for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) based on the EAN/PNS guideline 2021].
    Kuwabara S
    Rinsho Shinkeigaku; 2024 May; 64(5):321-325. PubMed ID: 38644208
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence and prevalence of CIDP and the association of diabetes mellitus.
    Laughlin RS; Dyck PJ; Melton LJ; Leibson C; Ransom J; Dyck PJ
    Neurology; 2009 Jul; 73(1):39-45. PubMed ID: 19564582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnosis of atypical forms of chronic inflammatory demyelinating polyradiculoneuropathy: a practical overview based on some case studies.
    Viala K
    Int J Neurosci; 2016 Sep; 126(9):777-85. PubMed ID: 26392214
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of 2021 European Academy of Neurology/Peripheral Nerve Society diagnostic criteria on diagnosis and therapy of chronic inflammatory demyelinating polyradiculoneuropathy variants.
    De Lorenzo A; Liberatore G; Doneddu PE; Manganelli F; Cocito D; Briani C; Fazio R; Mazzeo A; Schenone A; Di Stefano V; Cosentino G; Marfia GA; Benedetti L; Carpo M; Filosto M; Antonini G; Clerici AM; Luigetti M; Matà S; Rosso T; Lucchetta M; Siciliano G; Lauria Pinter G; Cavaletti G; Inghilleri M; Cantisani T; Notturno F; Ricciardi D; Habetswallner F; Spina E; Peci E; Salvalaggio A; Falzone Y; Strano C; Gentile L; Vegezzi E; Mataluni G; Cotti Piccinelli S; Leonardi L; Romano A; Nobile-Orazio E;
    Eur J Neurol; 2024 Apr; 31(4):e16190. PubMed ID: 38165011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society.
    Hughes RA; Bouche P; Cornblath DR; Evers E; Hadden RD; Hahn A; Illa I; Koski CL; Léger JM; Nobile-Orazio E; Pollard J; Sommer C; Van den Bergh P; van Doorn PA; van Schaik IN
    Eur J Neurol; 2006 Apr; 13(4):326-32. PubMed ID: 16643309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monocentric study of 28 cases of chronic inflammatory demyelinating polyneuropathy: first Tunisian study.
    Mansour M; Rachdi A; Baradai N; Kacem A; Bedoui I; Mrissa R
    Neurol Sci; 2022 Jan; 43(1):565-571. PubMed ID: 33945035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CIDP variants in diabetes: measuring treatment response with a small nerve fiber test.
    Névoret ML; Vinik AI
    J Diabetes Complications; 2015 Mar; 29(2):313-7. PubMed ID: 25466645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronic inflammatory demyelinating polyneuropathy in patients with systemic lupus erythematosus: prognosis and outcome.
    Vina ER; Fang AJ; Wallace DJ; Weisman MH
    Semin Arthritis Rheum; 2005 Dec; 35(3):175-84. PubMed ID: 16325658
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A case of CIDP with diabetes mellitus who had good response to intravenous immune globulin].
    Nakano M; Takase Y; Tatsumi C; Miura A; Matsuyama T; Kadekawa J; Yoshikawa H
    Rinsho Shinkeigaku; 2002 Jan; 42(1):32-4. PubMed ID: 12355849
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frequency of diabetes and other comorbidities in chronic inflammatory demyelinating polyradiculoneuropathy and their impact on clinical presentation and response to therapy.
    Doneddu PE; Cocito D; Manganelli F; Fazio R; Briani C; Filosto M; Benedetti L; Bianchi E; Jann S; Mazzeo A; Antonini G; Cosentino G; Marfia GA; Cortese A; Clerici AM; Carpo M; Schenone A; Siciliano G; Luigetti M; Lauria G; Rosso T; Cavaletti G; Beghi E; Liberatore G; Santoro L; Spina E; Peci E; Tronci S; Ruiz M; Cotti Piccinelli S; Verrengia EP; Gentile L; Leonardi L; Mataluni G; Piccolo L; Nobile-Orazio E;
    J Neurol Neurosurg Psychiatry; 2020 Oct; 91(10):1092-1099. PubMed ID: 32868387
    [TBL] [Abstract][Full Text] [Related]  

  • 40. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society.
    Joint Task Force of the EFNS and the PNS
    J Peripher Nerv Syst; 2005 Sep; 10(3):220-8. PubMed ID: 16221283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.